Member Company


atai Life Sciences is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health. Founded in 2018 as a response to the significant unmet need and lack of innovation in the mental health treatment landscape, atai is dedicated to acquiring, incubating, and efficiently developing innovative therapeutics, including psychedelic compounds and digital solutions to treat depression, anxiety, addiction, and other mental health disorders.

Copyright © 2024 Digital Therapeutics Alliance™